PRAVASTATIN Drug Patent Profile

Which patents cover Pravastatin, and what generic alternatives are available?

Pravastatin is a drug marketed by Accord Hlthcare, Apnar Pharma Lp, Apotex, Aurobindo Pharma, Aurobindo Pharma Usa, Biocon Pharma, Chartwell Rx, Cipla, Dr Reddys Labs Inc, Glenmark Pharms Ltd, Hisun Pharm Hangzhou, Norvium Bioscience, Pliva Hrvatska Doo, Ranbaxy Labs Ltd, Watson Labs, and Zydus Pharms Usa. and is included in eighteen NDAs.

The generic ingredient in PRAVASTATIN is pravastatin sodium. There are sixteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the pravastatin sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Pravastatin

A generic version of PRAVASTATIN was approved as pravastatin sodium by AUROBINDO PHARMA USA on April 24^th, 2006.

Summary for PRAVASTATIN

US Patents:	0
Applicants:	16
NDAs:	18
Drug Prices:	Drug price information for PRAVASTATIN
Drug Sales Revenues:	Drug sales revenues for PRAVASTATIN
DailyMed Link:	PRAVASTATIN at DailyMed

See drug prices for PRAVASTATIN

See drug sales revenues for PRAVASTATIN

US Patents and Regulatory Information for PRAVASTATIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	PRAVASTATIN SODIUM	pravastatin sodium	TABLET;ORAL	076939-004	Oct 23, 2006	AB	RX	No	No
Norvium Bioscience	PRAVASTATIN SODIUM	pravastatin sodium	TABLET;ORAL	077013-004	Dec 28, 2007		DISCN	No	No
Cipla	PRAVASTATIN SODIUM	pravastatin sodium	TABLET;ORAL	077904-004	Mar 22, 2016	AB	RX	No	No
Norvium Bioscience	PRAVASTATIN SODIUM	pravastatin sodium	TABLET;ORAL	079187-001	May 27, 2010		DISCN	No	No
Norvium Bioscience	PRAVASTATIN SODIUM	pravastatin sodium	TABLET;ORAL	079187-003	May 27, 2010		DISCN	No	No
Hisun Pharm Hangzhou	PRAVASTATIN SODIUM	pravastatin sodium	TABLET;ORAL	206061-001	Nov 23, 2018		DISCN	No	No